RubrYc Therapeutics announces Series A2 Preferred equity financing, collaboration, and RTX-003 license with iBio, Inc.

Must Read

RubrYc Therapeutics, Inc. (“RubrYc”) and iBio, Inc. (“iBio”, NYSEA: IBIO) announced today the closing of RubrYc’s Series A2 Preferred Financing, and concomitant License and Collaboration Agreements directed towards the …

Latest News

Police foils illegal trade of protected mobula ray species in Bali

Jembrana, Bali (ANTARA) - Jembrana District Police in Bali have unraveled a suspected illegal trade of protected mobula ray...

More Articles Like This